Atlas FDA

MONOVISC INJECTABLE INTRA-ARTICULAR DEVICES

FDA premarket approval P090031/S004 · decided 2015-05-05

Approval details

PMA number
P090031
Supplement
S004
Supplement type
135 Review Track For 30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
MONOVISC INJECTABLE INTRA-ARTICULAR DEVICES
Generic name
Acid, hyaluronic, intraarticular
Applicant
Anika Therapeutics, Inc.
Date received
2014-12-24
Decision date
2015-05-05
Days to decision
132 days
Decision code
APPR
Product code
MOZ
Advisory committee
Orthopedic
Expedited review
No
Location
Beford, MA
Statement
APPROVAL FOR AN ALTERNATE RAW MATERIAL SUPPLIER.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
Integrity™ Implant (K250997)Anika Therapeutics, Inc.2025-06-17
Tactoset® Injectable Bone Substitute (K231968)Anika Therapeutics, Inc.2023-12-20
Integrity Implant (K223538)Anika Therapeutics, Inc.2023-08-17
Integrity™ Bone Staple Fixation System (K223860)Anika Therapeutics, Inc.2023-05-22
Anika Tissue Tack Fixation System (K222487)Anika Therapeutics, Inc.2023-05-08
Tactoset (K223915)Anika Therapeutics, Inc.2023-03-29
Tactoset Injectable Bone Substitute (K212083)Anika Therapeutics, Inc.2021-08-31
SCS 17-01 (K190956)Anika Therapeutics, Inc.2020-01-30